The DOI matches its OpenAlex record; 1 of the 1 references it cites were found in a registry or an index.
Commentary--goodbye M(C)ID! Hello MID, where do you come from?
Open accessAbstract
Health-related quality of life (HRQL) has overcome many barriers that limited its acceptance as an important outcome in health care. One of the remaining barriers relates to how one should interpret HRQL scores when they change over time within patients, or differ between patients. Indeed, because there is no gold standard methodology, interpreting HRQL scores is a challenging task. While daunting, addressing the challenge of interpretability is crucial to moving the field forward. The choice of what constitutes an important difference in a HRQL score will influence judgments about the success of a health care intervention, the required sample size of clinical studies, and the design of these studies. The issue is relevant to clinicians, payers, funding agencies, and regulatory agencies, and most relevant to patients for whose health care these groups claim responsibility. Several approaches to assessing interpretability exist. Anchor-based approaches rely on examining the relation between scores on a HRQL instrument that is under investigation and an anchor, an independent measure of HRQL that clinicians can easily interpret (Guyatt et al. 2002). Other approaches for evaluation of interpretability of HRQL scores include distribution-based or statistical methods and reliance on experts (panel-based methods) (Lassere et al. 2001). Wyrwich and colleagues utilized the last of these alternatives to determine interpretability of the SF-36 by elegantly combining outcomes research with qualitative research methods (Wyrwich et al. 2003; 2005). This approach focuses on how clinician researchers view patients in relation to their HRQL scores and changes in HRQL scores. The article by Wyrwich's et al. is ingenious for several reasons. First, despite the wealth of literature evaluating the SF-36 as an outcome measure, evidence for the interpretability of the instrument is surprisingly limited. Second, Wyrwich and colleagues focus on three different clinician groups and estimates whether interpretability differs across these groups. Third, the judgments the clinician researchers made were based on detailed patient scenarios. In this commentary we will provide two arguments that readers should consider in the context of the work by Wyrwich and colleagues. First, we argue that research on the interpretability of HRQL instruments should focus primarily on the patient's view. Early work by our group pioneered the methodology of assessing interpretability of HRQL instruments (Jaeschke, Singer, and Guyatt 1989). In that work, we described what became widely known as the minimal clinical important difference (MCID). Because this terminology focuses attention on the clinical arena rather than patients' experience in their day-to-day lives, we subsequently removed the focus on “clinical” interpretations, and the “C” from MCID to focus on the minimal important difference (MID) (Juniper et al. 1994; Schunemann et al. 2005). HRQL is a patient important outcome because it is the patients who experience their HRQL, and only they are in a position to ultimately judge whether a difference is important (Guyatt et al. 2004). We now define the MID as the smallest difference in score in the outcome of interest that informed patients or informed proxies perceive as important, either beneficial or harmful, and which would lead the patient or clinician to consider a change in the management (Schunemann et al. 2005). The revised description of the MID precludes making MID estimates for outcomes that are remote from those important, in themselves, to patients, such as spirometry or laboratory exercise capacity. Further, the definition suggests that only if one had reason to question the reliability or accuracy of data from patients would one rely on proxies to provide estimates of the MID. Investigators or clinicians may differ in the perspective or the methodology they adopt to determine the MID. Thus, readers, when they interpret the results of research on the MID, must attend to who rated the importance of an HRQL change and the specific instructions provided for making the assessment. If one accepts that HRQL measurement must be fundamentally patient-centered, the first choice for establishing the MID should be a patient-based approach. Relative to patients, clinicians may overemphasize treatment effects (Puhan et al. 2004) and agreement between patients and proxies in rating of HRQL is not perfect (Sneeuw, Sprangers, and Aaronson 2002; Ubel, Loewenstein, and Jepson 2003; von Essen 2004). Again, if one accepts that patients are at the center in HRQL measurement, then investigators, when they do use proxies, should instruct those proxies to focus on what they believe patients consider important. Wrywich and colleagues took a different approach. “Panelists were not provided with any specific definition of a CID (clinically important difference), but left to determine their own meaning for this term” (p. 580). Thus, the in
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaeschke, R., Singer, J., & Guyatt, G. H. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90005-6 · Cited by 4,982
Self-citation
Cited by
Reddel, H. K., Taylor, D. R., Bateman, E. D., Boulet, L.-P., Boushey, H. A., Busse, W. W., Casale, T. B., Chanez, P., Enright, P. L., Gibson, P. G., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200801-060st · Cited by 1,918
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
Reeve, B. B., Wyrwich, K. W., Wu, A. W., Velikova, G., Terwee, C. B., Snyder, C. F., Schwartz, C., Revicki, D. A., Moinpour, C. M., McLeod, L. D., et al. (2013) · Quality of Life Research · doi:10.1007/s11136-012-0344-y · Cited by 845
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis
Busse, J. W., Wang, L., Kamaleldin, M., Craigie, S., Riva, J. J., Montoya, L., Mulla, S. M., Lopes, L. C., Vogel, N., Chen, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.18472 · Cited by 716
Self-citationA point of minimal important difference (MID): a critique of terminology and methods
King, M. T. (2011) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.11.9 · Cited by 646
Metadata
- Authors
- Schünemann, H. J., & Guyatt, G. H.
- Venue
- PubMed
- Publisher
- National Institutes of Health
- Published
- 2005-04-01
- Volume
- 40
- Issue
- 2
- Pages
- 593-7
- OpenAlex
- W2127704316
- Cited by
- 210
- References
- 1
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Commentary--goodbye M(C)ID! Hello MID, where do you come from? https://app.cochat.ai/papers/10.1111/j.1475-6773.2005.00374.x
- The paper
- Schünemann, H. J., & Guyatt, G. H. (2005). Commentary--goodbye M(C)ID! Hello MID, where do you come from? PubMed. https://doi.org/10.1111/j.1475-6773.2005.00374.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.